SPRING DNA
Live / Applied — New application — not yet assigned to an examiner (as of 09 Mar 2023)
What this means for you
Not registered yet, but its 19 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97801754
- Mark type
- Stylized text
- Filed
- 19 Feb 2023
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations for gene therapy and genetic vaccination
- Class 042 — Scientific and technological services: Development of gene-based medicines; Development of pharmaceutical preparations and medicines; Gene therapy research; Genetic testing for scientific research purposes; Laboratory research in the field of gene expression, gene editing, RNAi and nucleic acid sciences; Research and development in the field of gene expression systems, gene delivery, genetic vector, DNA vectors, non-viral genetic vectors, diagnostics, cosmetics, RNAi, mRNA, synthetic DNA manufacturing, in vitro transcription, gene editing, genetic vaccination, immunology, gene therapy, oncology, RNA trans-splicing, linear DNA, hairpin DNA, dumbbell DNA, plasmids, RNA, mitochondrial gene therapy, polymerase chain reaction, ligands, conjugates, helper functions, aptamers, antibodies, gap primers, gap primer PCR; Research and development of vaccines; Vaccine research and development; Product development in the field of gene-based medicines, gene therapy, diagnostics and genetic vaccination; Providing information about medical research in the field of gene therapy and genetic vaccination; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing scientific research information in the field of genetic vaccination, gene therapy, and diagnostics; Research and development of vaccines and medicines; Research and development services in the field of gene expression systems; Research in the field of gene editing technology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- AVECRIS PTE. LTD., Singapore, SG
Prosecution history
- 18 Aug 2025 — WITHDRAWAL OF ATTORNEY GRANTED
- 18 Aug 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 09 Mar 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Feb 2023 — NEW APPLICATION ENTERED